Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AbbVie Seeking to Delay Androgel Bellwether Lawsuit Selection: Plaintiffs May 13, 2015 Austin Kirk Add Your Comments As a growing number of Androgel lawsuits continue to be filed by men throughout the federal court system, all involving similar allegations that AbbVie failed to adequately warn about the risk of heart attacks, blood clots and other side effects associated with the popular testosterone replacement therapy, plaintiffs indicate that the drug maker is raising unnecessary objections in an attempt to delay the bellwether trial selection process in the federal multidistrict litigation (MDL). AbbVie currently faces about 800 product liability lawsuits filed in U.S. District Courts nationwide involving use of the testosterone gel Androgel, which recent studies have linked to serious and potentially life-threatening cardiovascular risks. Given the nearly identical failure to warn claims raised in the Androgel cases, as well as other testosterone drug lawsuits filed against manufacturers of less popular products, the federal litigation has been centralized as part of an MDL before Matthew Kennelly in the Northern District of Illinois. Learn More About Testosterone Lawsuits Testosterone Gel, Patches, Injections or other Treatments May Cause Heart Attacks, Strokes, Wrongful Death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Testosterone Lawsuits Testosterone Gel, Patches, Injections or other Treatments May Cause Heart Attacks, Strokes, Wrongful Death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION As part of the coordinated pretrial proceedings in the MDL, the parties have been directed to exchange fact sheets containing specific information about each claim, so that a small group of Androgel injury lawsuits can be selected for a bellwether process. These cases will be prepared for early trial dates next year, which are designed to help the parties gauge how juries may respond to certain evidence and testimony that is likely to be repeated throughout the testosterone litigation. Objections to Plaintiff Fact Sheets Submitted in Androgel Cases Earlier this month, AbbVie filed a submission (PDF) with the Court over the Plaintiff Fact Sheets (PFS), indicating that information about many of the cases have not been timely filed or have contained deficiencies. As a result, the drug maker seeks an extension of the time provided for identifying the group of bellwether cases, and has requested other changes in the selection process that plaintiffs describe as “extraordinary.” In a response (PDF) filed by the Plaintiffs’ Steering Committee (PSC) on May 11, attorneys for users of the popular drugs argue that the complaints raised by AbbVie are unfounded and that the issue has been raised by new counsel for the drug maker to disrupt a schedule agreed to by AbbVie through its prior attorneys. “The real purpose of AbbVie’s attacks on the PFS process has been a transparent attempt to unwind the bellwether trial schedule and delay, as much as possible, the pace and progress of this litigation,” according to the plaintiffs memorandum filed in opposition to the drug maker’s submission. “The AbbVie Brief is the next milestone in this months-long effort to undermine the schedule for selecting bellwether trial cases.” Plaintiffs indicate that over 92.5% of the PFS that were due earlier this month were served by the May 8 deadline, and that even if there are deficiencies, the prior case management order provides a deficiency dispute resolution process and a 45 day period to allow the submissions to be cured. Therefore, Judge Kennelly has been urged to deny AbbVie’s requests. According to a Docket Entry (PDF) issued on the issue, any reply by AbbVie must be filed today and the Court is expected to make a ruling by Friday. Androgel Bellwether Trial Process According to a prior case management order outlining the process for preparing Androgel bellwether lawsuits for trial, a group of 32 cases are supposed to be identified by the parties before October 31, 2015. Each side will identify eight lawsuits involving a blood clot injury from Androgel, and another eight lawsuits each involving a heart injury from the testosterone drug side effects. These claims will then go through case-specific discovery and be reduced down to a series of six trial dates that are expected to begin about one-per-month between October 2016 and April 2017. A separate series of testosterone bellwether trials are expected involving drugs not manufactured by AbbVie, such as Testim lawsuits, Axiron lawsuits, Androderm lawsuits or claims involving other low T drugs. A process for selecting those claims is not expected until later this year, and the trials will not begin until at least mid-2017. While these early trial dates will be closely watched by testosterone injury lawyers involved in the litigation, the outcomes will not be binding on any other lawsuits. However, the bellwether cases may heavily influence eventual negotiations to reach Androgel settlements that avoid the need for AbbVie to face hundreds of individual jury trials throughout the country. Tags: AbbVie, AndroGel, Axiron, Depo-Testosterone, Heart Attack, Stroke, Testim, Testosterone, Testosterone Gel Image Credit: | More Testosterone Lawsuit Stories Link Between Testosterone Drugs and Heart Risks Not Found in New Study June 19, 2023 Study’s Findings Question Link Between Testosterone Drugs and Blood Clots October 26, 2021 New Testosterone Guidelines Warn Against Unnecessary Use, Prefer Shots Over Transdermal Products January 10, 2020 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Bard PowerPort Infection Lawsuit Chosen for First Bellwether Trial in Feb. 2026 (Posted: yesterday) A federal judge has selected a Bard PowerPort infection lawsuit to serve as the first in a series of bellwether trials over claims the port catheters were defectively designed. MORE ABOUT: BARD POWERPORT LAWSUITCook Medical Angiographic Catheter Recall Issued Following Multiple Reports of Serious Injury: FDA (06/27/2025)More Than 1,700 Bard PowerPort Lawsuits Now Filed in State and Federal Courts (06/03/2025)6 Bard PowerPort Lawsuits Selected for Bellwether Trials in Federal MDL (05/19/2025) Status of Hair Dye Bladder Cancer Lawsuits Outlined for Court (Posted: 2 days ago) One hair dye bladder cancer lawsuit out of at least 15 filed to date has been chosen as the lead case against several cosmetics manufacturers. MORE ABOUT: HAIR DYE LAWSUIT12 Hair Dye Lawsuits Over Bladder Cancer Risks Assigned to One Judge in California State Court (07/01/2025)Judge To Meet With Hair Dye Lawyers in Bladder Cancer Lawsuit for Initial Status Conference (06/16/2025)Lawsuit Claims Paul Mitchell, Redken, Other Hair Dyes Led to Bladder Cancer Diagnosis for Hairdresser (05/09/2025) Social Media Addiction Lawsuit Set for Trial in California State Court in November 2025 (Posted: 2 days ago) A series of social media addiction lawsuit trials will begin this November in California state court, as federal bellwether cases are prepared for likely 2026 trial dates. MORE ABOUT: SOCIAL MEDIA ADDICTION LAWSUITSnapchat Lawsuit Claims Platform Unleashed Experimental AI on Children Without Safeguards (07/09/2025)Fortnite Settlement Provides $126M in Payouts to Players Targeted With Unwanted Items: FTC (07/01/2025)Video Game Addiction Can Begin as Early as Elementary School: Study (06/27/2025)
New Testosterone Guidelines Warn Against Unnecessary Use, Prefer Shots Over Transdermal Products January 10, 2020
Bard PowerPort Infection Lawsuit Chosen for First Bellwether Trial in Feb. 2026 (Posted: yesterday) A federal judge has selected a Bard PowerPort infection lawsuit to serve as the first in a series of bellwether trials over claims the port catheters were defectively designed. MORE ABOUT: BARD POWERPORT LAWSUITCook Medical Angiographic Catheter Recall Issued Following Multiple Reports of Serious Injury: FDA (06/27/2025)More Than 1,700 Bard PowerPort Lawsuits Now Filed in State and Federal Courts (06/03/2025)6 Bard PowerPort Lawsuits Selected for Bellwether Trials in Federal MDL (05/19/2025)
Status of Hair Dye Bladder Cancer Lawsuits Outlined for Court (Posted: 2 days ago) One hair dye bladder cancer lawsuit out of at least 15 filed to date has been chosen as the lead case against several cosmetics manufacturers. MORE ABOUT: HAIR DYE LAWSUIT12 Hair Dye Lawsuits Over Bladder Cancer Risks Assigned to One Judge in California State Court (07/01/2025)Judge To Meet With Hair Dye Lawyers in Bladder Cancer Lawsuit for Initial Status Conference (06/16/2025)Lawsuit Claims Paul Mitchell, Redken, Other Hair Dyes Led to Bladder Cancer Diagnosis for Hairdresser (05/09/2025)
Social Media Addiction Lawsuit Set for Trial in California State Court in November 2025 (Posted: 2 days ago) A series of social media addiction lawsuit trials will begin this November in California state court, as federal bellwether cases are prepared for likely 2026 trial dates. MORE ABOUT: SOCIAL MEDIA ADDICTION LAWSUITSnapchat Lawsuit Claims Platform Unleashed Experimental AI on Children Without Safeguards (07/09/2025)Fortnite Settlement Provides $126M in Payouts to Players Targeted With Unwanted Items: FTC (07/01/2025)Video Game Addiction Can Begin as Early as Elementary School: Study (06/27/2025)